SBC / revenue moved 19101 bp higher
SBC / revenue changed +19101 basis points from the comparable as-filed period.
10.94%→201.95%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CNSY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
R&D / revenue moved 94807 bp higher
R&D / revenue changed +94807 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
89.64%→1037.71%2 prior comparisons
Current liabilities increased 17.1%
Current liabilities changed +17.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$7.3M→$8.6M4 prior comparisons
Working capital / assets moved 450 bp higher
Working capital / assets changed +450 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
18.34%→22.84%4 prior comparisons
Free-cash-flow margin moved 143907 bp lower
Free-cash-flow margin changed -143907 basis points from the comparable as-filed period.
-417.63%→-1856.69%2 prior comparisons
Operating cash-flow margin moved 131816 bp lower
Operating cash-flow margin changed -131816 basis points from the comparable as-filed period.
-417.12%→-1735.28%2 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +7028.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$7,000→$499,0003 prior comparisons
Cash & equivalents increased 6.0%
Cash & equivalents changed +6.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2M→$2.4M4 prior comparisons
Current ratio increased 9.1%
Current ratio changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.26→1.374 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.